John Horowitz
机构: University of Adelaide
每年引用次数
引用次数
引用: 40,068
H-指数: 83
I10-指数 : 310
出版物: 801
Рамиприл повышает чувствительность тромбоцитов к оксиду азота. Значение этого феномена для лечения больных с высоким сердечно-сосудистым риском
T. Heresztyn , E. A. Liberts , S. R. Willoughby , J. D. Horowitz
Рациональная фармакотерапия в кардиологии 8 ( 4)
2012
Interleukin-6 and C-reactive protein and risk for cardiovascular events and death in anticoagulated patients with atrial fibrillation
B. J. Gersh , E. M. Hylek , Agneta Siegbahn , J. D. Horowitz
European Heart Journal 35 1115 -1116
1
2014
Evaluation prospective de l'imagerie par résonance magnétique dans les infections aiguës du pied diabétique
J. G. Wright , B. Nease , J. D. Horowitz , M. L. Lukens
Annales De Chirurgie Vasculaire 7 ( 1) 44 -50
1993
Angioplastie transluminale per-cutanée des artères de jambe pour sauvetage de membre chez des malades diabétiques à haut risque
W. L. Smead , J. D. Horowitz , J. R. Durham , J. Gordon Wright
Annales De Chirurgie Vasculaire 8 ( 1) 48 -53
1994
Apical variant Tako-tsubo is associated with persistent myocardial strain dysfunction
M. P. Frenneaux , J. D. Horowitz , C. J. Neil , K. Schwarz
European Heart Journal 36 943 -944
1
2015
Do all heart failure patients benefit from high dose Lisinopril? Results from the ATLAS study
J. D. Horowitz , L. Ryden , P. W. Armstrong , J. G. F. Cleland
Journal of the American College of Cardiology 35(2 suppl A) 203
2000
A home-based intervention reduced out-of-hospital deaths and hospitalizations in CHF
J. D. Horowitz , S. Pearson , S. Stewart , A. J. Vandenbroek
Evidence-based Medicine 4 ( 4)
1999
Frequency and clinical significance of T-wave fluctuation immediately following percutaneous transluminal coronary angioplasty
J. D. Horowitz , A. Kucia , K. South
European Heart Journal 22(Abstract Suppl.) 215
2001
Incidence, duration and outcome of recurrent ST-segment elevation in the first 24 hours post commencement of thrombolytic therapy for acute myocardial infarction
J. D. Horowitz , A. Kucia , J. M. Briggs
European Heart Journal 21(Abstract Suppl.) 32
2000
Verapamil in unstable angina pectoris: failure to demonstrate a relationship between efficacy and plasma levels.
A. C. Powell , S. L. Elliott , J. D. Horowitz
Therapeutic Drug Monitoring 10 ( 1) 34 -38
3
1988
Redefining the natural history of calcific aortic stenosis: lessons from Laennec
A. L. Sverdlov , D. T. Ngo , J. D. Horowitz
Journal of Internal Medicine 271 ( 6) 569 -572
1
2012
Comparative trial of mexiletine and lignocaine in the treatment of early ventricular tachyarrhythmias after acute myocardial infarction.
J. D. Horowitz , S. N. Anavekar , P. M. Morris , A. J. Goble
Journal of Cardiovascular Pharmacology 3 ( 3) 409 -419
27
1981
The prevalence of ST-segment depression on ambulatory electrocardiographic monitoring during daily life in high-risk asymptomatic police officers.
M. A. Arstall , R. D. Wuttke , J. Arthur , J. A. Whitford
Journal of Cardiovascular Risk 1 ( 2) 143 -148
1
1994
ADMA and SDMA predict outcomes in patients with chronic atrial fibrillation: an ARISTOTLE substudy
J. D. Horowitz , R. De Caterina , T. Heresztyn , U. Andersson
European Heart Journal 34 1040 -1041
4
2013
Purification of a Peptide with Venoconstrictor and Vasodepressor Activity, from Cohn Fraction III-O of Human Plasma Protein
J. D. Horowitz , M. L. Mashford
Vox Sanguinis 38 ( 5) 259 -265
1980
Venoconstrictor activity of some precursor fractions of stable plasma protein solution.
J. D. Horowitz , M. L. Mashford
Vox Sanguinis 38 ( 5) 266 -271
1
1980
Multiple agonist induction of aggregation: an approach to examine anti-aggregating effects in vitro
S. R. Willoughby , L. P. Chirkova , J. D. Horowitz , Y. Y. Chirkov
Platelets 7 329 -333
6
1996
Absorption Kinetics of Low Dose Aspirin in Patients with Evolving Acute Myocardial Infarction
C. L. Zhang , K. M. Wilson , I. Stafford , F. Bochner
Drug Investigation 7 ( 4) 169 -174
7
1994
A Vasodepressor Peptide in Cohn Fraction III-0 of Human Plasma Proteins
J. D. Horowitz , M. L. Mashford
Kinins 70 15 -21
3
1976
HAEMODYNAMIC EFFECTS OF A SINGLE LOW DOSE OF PRAZOSIN IN PATIENTS WITH CHRONIC CONGESTIVE CARDIAC FAILURE CORRELATIONS WITH PHARMACOKINETICS
J. D. Horowitz , M. K. Dynon , B. Jarrott , J. B. Brennan
Clinical and Experimental Pharmacology and Physiology 11 ( 1) 7 -15
3
1984